Ironwood Pharmaceuticals
Ironwood Pharmaceuticals, Inc.
301 Binney Street
Cambridge, MA 02142
Phone: (617) 621 7722Website: https://www.ironwoodpharma.comCareers: www.ironwoodpharma.com/join-us
Latest news
- FDA Approves Duzallo (lesinurad and allopurinol) for Hyperuricemia in Patients with Uncontrolled Gout
21 August 2017 - Ironwood Announces New Drug Application for Duzallo (Fixed-Dose Combination of Lesinurad and Allopurinol) Has Been Accepted for FDA Review
4 January 2017 - FDA Approves Zurampic (lesinurad) to Treat High Blood Uric Acid Levels Associated with Gout
22 December 2015 - FDA Advisory Committee Recommends the Approval of Lesinurad for Gout Patients
23 October 2015
Drugs Associated with Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals, Inc. manufactures, markets and/or distributes 1 drug in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Linzess
Generic name: linaclotide Drug class: guanylate cyclase-C agonists |
803 reviews | 6.7 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||